Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8.

[1]  P. Murphy,et al.  Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.

[2]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[3]  N. Kawada,et al.  Effects of arachidonic acid metabolites and interleukin‐1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice , 1991, Journal of gastroenterology and hepatology.

[4]  M. Baggiolini,et al.  Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a. , 1991, Biochemical and biophysical research communications.

[5]  M. Vadas,et al.  Granulocyte-macrophage colony-stimulating factor is a stimulant of platelet-activating factor and superoxide anion generation by human neutrophils. , 1991, The Journal of biological chemistry.

[6]  M. Rola-Pleszczynski,et al.  Immune Regulation by Platelet‐Activating Factor: II. Mediation of Suppression by Cytokine‐Stimulated Endothelial Cells In Vitro , 1991, Journal of leukocyte biology.

[7]  B. Dewald,et al.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8 , 1991, The Journal of experimental medicine.

[8]  C. McCall,et al.  Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. , 1991, Journal of immunology.

[9]  D. Gingras,et al.  Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. , 1991, Immunology.

[10]  Takao Shimizu,et al.  Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.

[11]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[12]  D. Riches,et al.  The subcellular distribution of platelet-activating factor in stimulated human neutrophils. , 1990, Journal of immunology.

[13]  G. Zimmerman,et al.  Platelet-activating Factor , 1991 .

[14]  T. Casale,et al.  Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species. , 1990, Journal of immunology.

[15]  D. Spriggs,et al.  Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Triggiani,et al.  Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. , 1990, Journal of immunology.

[17]  G. Dusting,et al.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Dinarello,et al.  Immunoregulatory functions of paf-acether. IV. Enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes. , 1990, Journal of immunology.

[19]  J. Schifferli,et al.  NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. , 1990, Biochemical and biophysical research communications.

[20]  G. Camussi,et al.  Release of platelet-activating factor in systemic lupus erythematosus. , 1990, International archives of allergy and applied immunology.

[21]  M. Kazatchkine,et al.  Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1). , 1989, The Journal of biological chemistry.

[22]  B. Dewald,et al.  The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils , 1989, The Journal of experimental medicine.

[23]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[24]  M. Yamada,et al.  Production and characterization of recombinant human neutrophil chemotactic factor. , 1989, Journal of biochemistry.

[25]  C. Dubois,et al.  Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors. , 1989, Journal of immunology.

[26]  T. Molski,et al.  Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Camussi,et al.  Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor , 1989 .

[28]  R. N. Pinckard,et al.  Alkyl chain homologs of platelet-activating factor and their effects on the mammalian heart. , 1989, Biochemical and biophysical research communications.

[29]  J. Pober,et al.  IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. , 1989, Journal of immunology.

[30]  A. D. de Weck,et al.  Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine. , 1989, Journal of immunology.

[31]  F. Herrmann,et al.  Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes. , 1989, The Journal of clinical investigation.

[32]  J. O'flaherty,et al.  Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. , 1989, The Journal of biological chemistry.

[33]  C. Nathan.  Respiratory burst in adherent human neutrophils: triggering by colony- stimulating factors CSF-GM and CSF-G , 1989 .

[34]  L. Epstein,et al.  Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. , 1988, Journal of immunology.

[35]  R. Johnston,et al.  The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. , 1988, Journal of immunology.

[36]  F. Chilton,et al.  1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil. , 1988, The Journal of biological chemistry.

[37]  T. Molski,et al.  Activation of the neutrophil. , 1988, Progress in allergy.

[38]  G. Zimmerman,et al.  Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. , 1987, The Journal of biological chemistry.

[39]  W. Fiers,et al.  Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187. , 1987, Clinical and experimental immunology.

[40]  G. Camussi,et al.  Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor , 1987, The Journal of experimental medicine.

[41]  R. Wykle,et al.  Stimulated neutrophils produce an ethanolamine plasmalogen analog of platelet-activating factor. , 1987, The Journal of biological chemistry.

[42]  G. Zimmerman,et al.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. , 1987, Journal of Immunology.

[43]  L. Touqui,et al.  Perspectives in platelet-activating factor research. , 1987, Pharmacological reviews.

[44]  A. Mantovani,et al.  Expression of c-fos protooncogene in normal human peripheral blood granulocytes , 1987, The Journal of experimental medicine.

[45]  W. Pickett,et al.  Species-specific variations in the molecular heterogeneity of the platelet-activating factor. , 1987, Journal of immunology.

[46]  A. Mantovani,et al.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. , 1987, Journal of immunology.

[47]  G. Camussi,et al.  Production of platelet-activating factor by chick retina. , 1986, The Journal of biological chemistry.

[48]  J. Gamble,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. , 1986, The Journal of clinical investigation.

[49]  A. Mantovani,et al.  Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. , 1986, Pharmacological research communications.

[50]  J. C. Ludwig,et al.  Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. , 1985, Biochemical and biophysical research communications.

[51]  M. Oda,et al.  Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor. , 1985, Biochemical and biophysical research communications.

[52]  J. O'flaherty,et al.  Neutrophil degranulation: Evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet‐activating factor, and 5‐HETE , 1985, Journal of cellular physiology.

[53]  D. Golde,et al.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator , 1985, Nature.

[54]  J. O'flaherty,et al.  The molecular species distribution of platelet-activating factor synthesized by rabbit and human neutrophils. , 1984, The Journal of biological chemistry.

[55]  E. Corey,et al.  Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. , 1984, The Journal of clinical investigation.

[56]  D. Lenihan,et al.  Increased biosynthesis of platelet-activating factor in activated human eosinophils. , 1984, The Journal of biological chemistry.

[57]  J. O'flaherty,et al.  Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. , 1983, The Journal of biological chemistry.

[58]  J. O'flaherty,et al.  Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. , 1982, The Journal of biological chemistry.

[59]  S. Robins,et al.  Separation of phospholipids and individual molecular species of phospholipids by high-performance liquid chromatography. , 1982, Journal of lipid research.

[60]  J. O'flaherty,et al.  Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. , 1981, The American journal of pathology.

[61]  L. McManus,et al.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). , 1981, Journal of immunology.

[62]  G. Camussi,et al.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. , 1981, Immunology.

[63]  P. Henson,et al.  Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil. , 1980, Journal of immunology.

[64]  J. Liehr,et al.  Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. , 1980, The Journal of biological chemistry.

[65]  E. Goetzl,et al.  Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. , 1980, Biochemical and biophysical research communications.

[66]  D. Hanahan,et al.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.

[67]  H. Khorana,et al.  Glycerophospholipid synthesis: improved general method and new analogs containing photoactivable groups. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[68]  K. Waku,et al.  Hydrolyses of 1-O-alkyl-, 1-O-alkenyl-, and 1-acyl-2-(1- 14 C)-linoleoyl-glycero-3-phosphorylcholine by various phospholipases. , 1972, Journal of biochemistry.

[69]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.